Director, Chief Executive Officer · Candel Therapeutics, Inc. · Common Stock
Side
M
Value
$194K
Shares
125.0K
Price
$1.55
Executed
Sep 10, 2026
Disclosed
Sep 11, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Sep 10 executedSep 11, 2026 disclosed
CADL · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+12 / 25
$194K reported value · 46.5% of prior position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Tak Paul Peter filed this Form 4 reporting a option exercise of CADL on Sep 10, 2026. It became public on Sep 11, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, Chief Executive Officer
Tak Paul Petercik:0001873905
Issuer
Candel Therapeutics, Inc.cik:0001841387
Revision history · 0
No field has changed since this record was first ingested.
